San Francisco startup Framework Therapeutics is additionally working on an oral, as soon as-each day GLP-1 drug called GSBR-1290—the drug surpassed Wall Avenue’s anticipations in June every time a mid-stage analyze showed typical weight loss of about six% and it programs to start out An additional mid-stage demo in the direction of the end of t… Read More